Evan Prescott Bailey - 15 Jun 2025 Form 3 Insider Report for Applied Therapeutics, Inc. (APLT)

Signature
/s/ Leslie D. Funtleyder, as attorney-in-fact
Issuer symbol
APLT
Transactions as of
15 Jun 2025
Net transactions value
$0
Form type
3
Filing time
17 Jun 2025, 16:08:49 UTC
Next filing
03 Feb 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Bailey Evan Prescott Chief Medical Officer C/O APPLIED THERAPEUTICS, INC., 545 FIFTH AVENUE, SUITE 1400, NEW YORK /s/ Leslie D. Funtleyder, as attorney-in-fact 17 Jun 2025 0002071667

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding APLT Common Stock 541,669 15 Jun 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding APLT Stock Option (Right to Buy) 15 Jun 2025 Common Stock 19,531 $1.50 Direct F1
holding APLT Stock Option (Right to Buy) 15 Jun 2025 Common Stock 4,883 $1.50 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options are fully vested.
F2 Consists of compensatory Options granted under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. One-fourth (1/4th) of the shares subject to the compensatory Option vested on April 13, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to the compensatory Option shall vest each month thereafter, subject to the Reporting Person continuing to provide services through each such date.